You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
京新藥業(002020.SZ):公司山東化學基地項目分期分批實施,預計會對公司化學原料藥業務產生積極影響
格隆匯 04-19 10:00

格隆匯4月19日丨有投資者通過深交所互動易向京新藥業(002020.SZ)提問,“公司預計山東項目投產後,可為公司貢獻的營收增長多少增幅?”

京新藥業回覆稱,公司山東化學基地項目分期分批實施,該項目首先是解決現有原料藥的產能限制,承接現有原料藥基地的部分產能需求,使原料藥、製劑的一體化配套能力全面提升;其次是擴大現有化學品的範圍和種類,進行API和中間體基地的專業化分工,提高生產效率。隨着項目逐漸建成投產,預計會對公司化學原料藥業務產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account